Baseline Angiography Subgroup Sees Prasugrel Benefit Baseline Angiography Subgroup Sees Prasugrel Benefit

It's not that angiography led to some unprecedented therapeutic benefit, investigators caution; rather, it signaled a group of patients who actually did better on prasugrel than clopidogrel in this otherwise negative trial. Heartwire
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news